http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20110018-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89d98da599a7fb715284473aee477c77
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
filingDate 2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7308d869f774d9843ed7a107eee90188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea742c3238b6f4fcdd0314872b39a6b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d50925960438a34edcc9f48b323b018b
publicationDate 2011-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20110018-A1
titleOfInvention COMPOSITION AND USE OF AUTO-EMULSIONABLE SOLUTION BASED ON TRICLABENDAZOLE SULFOXIDE IN COMBINATION WITH AVERMECTINS FOR THE TREATMENT OF FASCIOLASIS, NEMATODIASIS AND ECTOPARASITOSIS
abstract IT REFERS TO A VETERINARY COMPOSITION OF A SELF-EMULSIBLE INJECTABLE SOLUTION THAT INCLUDES: A) TRICLABENDAZOLE SULFOXIDE IN AN AMOUNT OF 1% TO 40% P / V; B) AN AVERMECTIN SUCH AS IVERMECTIN, DORAMECTIN, EPRINOMECTIN, AMONG OTHERS, IN A QUANTITY OF 0.05% TO 10% P / V; C) AN ORGANIC SOLVENT SUCH AS N-METHYL-2-PYRROLIDONE, 2-PIRROL, GLYCEROL FORMAL, AMONG OTHERS, IN AN AMOUNT OF 1% TO 40%; D) BENZYL ALCOHOL IN AN AMOUNT OF 1% TO 20%; E) A SURFACTANT SUCH AS MACROGOL 15 HYDROXIESTEARATE, POLYETOXYLATE CASTOR OIL, POLYETOXYLATE 80, AMONG OTHERS, IN AN AMOUNT OF 1% TO 40% P / V; F) AN ANTIOXIDANT SUCH AS PROPYL GALATE, SODIUM SULPHITE, AMONG OTHERS, IN AN AMOUNT OF 0.001% TO 0.15% P / V; AND G) OPTIONAL COMPONENTS SUCH AS METHYLPARABENE, BUTYLPARABENE, POLYVINYLPYRROLIDONE, AMONG OTHERS. IT ALSO REFERS TO A METHOD OF PREPARATION. SUCH COMPOSITION IS USEFUL FOR THE TREATMENT OF FASCIOLASIS, NEMATODIASIS AND ECTOPARASITOSIS
priorityDate 2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416175303
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9832750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415826477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9897322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426110345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426151701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6450531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419561490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426366346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID127657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449013851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2761212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547614

Total number of triples: 37.